Cancel

Novel Artificial Pancreas for Hospital that Improves Care at Lower Cost

Novel Artificial Pancreas for Hospital that Improves Care at Lower Cost

Novel artificial pancreas for hospital and surgical care that improves healthcare at lower costs.

Project milestone

In Development

Idea Complete
Prototype Complete
In Development
Deployed
Commercialized

Impact statement

Proper control of blood glucose levels and avoidance of harmful low levels saves lives (34% mortality reduction), decreases complications (by 40–50% over numerous co-morbidities), and speeds recovery (by 1.8 days in critical care patients). Foremost, this is a fundamental standard of care issue, increasingly cited by regulatory and standards bodies. Understanding of this need is becoming a key financial driver for hospitals as well, with impact both on revenue (from outcome-based reimbursement) and cost savings (independently shown to be $7,500+ per patient).